Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Inc.
WKN: 882807 / Symbol: VRTX / Name: Vertex / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
393,75 €
-0,10 %
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Evercore ISI. They now have a $530.00 price target on the stock, up previously from $475.00.
Ratings data for VRTX provided by MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for VRTX provided by MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Ratings data for VRTX provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Vertex Pharmaceuticals Inc. diskutieren